May 2021

ASHG: I understand you had a follow-up interview with an employer because of the Career Fair. Can you tell me more about how that came about? Kritika Shankar: Cleveland Clinic was one of the exhibits at the ASHG virtual career fair this year. I have known about Cleveland Clinic and their research for many years... Read More

Robin Aguilar (they/them/elle) is a Ph.D. Candidate at the University of Washington in the Department of Genome Sciences developing software tools to study and image satellite DNA. Beyond their thesis work, Robin develops curricula, shares their experiences via writing, and creates art to make STEM and genomics more accessible. Robin recently published a Nature Career... Read More

Genetics research is providing remarkable insights into the human genome and how this knowledge can be translated into healthcare advances. This scientific progress relies on continued public investment in biomedical research. ASHG supports the robust, predictable, sustainable federal funding of research to fuel scientific advances. Related: Written Testimony to Senate Appropriations LHHS Subcommittee (May 2023)... Read More

A new report commissioned by ASHG examines how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion to the U.S. economy... Read More

*Editors Note: Data provided in an early version of the press release was incorrect related to the number of people worldwide being treated for rare diseases. These conditions affect 25-30 million people in the U.S. and 350 million worldwide. Published: May 19, 2021, 8:00 a.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org   Economic Analysis Shows... Read More